Skip to content

FinalDose

YC X26 · Active · Programmable DNA drug destroying all cancers, unlocking 80% of targets

Competitors

Adjacent

Also from X26 in AI

All of X26

Founders

  • Jeff LiuFounder/CEO
  • Li-Yao HuangFounder
  • Steven LinFounder

About FinalDose

FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.

YC batch
X26 · Spring 2026
Status, per YC
Active
Category
AI
Team size
5
Location
Oxford, England, United Kingdom
Founded
2025
Checked
4h ago

YC tags: Artificial Intelligence, Gene Therapy, Therapeutics, Genetic Engineering

FinalDose in X26: 193 companies, 84% AI

LinkedIn

FinalDose: questions

Which YC batch was FinalDose in?

FinalDose was in Y Combinator's Spring 2026 batch (X26).

Is FinalDose still active?

Y Combinator lists FinalDose as active.

Who founded FinalDose?

FinalDose's founders, as listed on its YC page: Jeff Liu (Founder/CEO), Li-Yao Huang (Founder), Steven Lin (Founder).

Where is FinalDose based?

FinalDose lists Oxford, England, United Kingdom as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.